21 March 2025
We are excited to announce the release of our latest Environmental, Social, and Governance (ESG) report. This detailed document showcases our significant achievements from November 2023 to October 2024, as well as describing all our ESG activities and processes.
Leading independent consultancy Oxford PharmaGenesis is pioneering the innovative discipline of HealthScience. For the first time, this integrates the clinical and scientific dimensions of healthcare with the economic, social, behavioural and political perspectives that determine the value of new medicines and health interventions.
Addressing heart failure must be considered a global health priority because poor awareness of the disease leads to many premature deaths. Approximately 26 million people are living with heart failure worldwide, and if current trends continue the disease will impose ever-increasing burdens on patients, caregivers and healthcare systems.
Recent announcements regarding Government investments in Oxfordshire are good news for those working within biosciences in the county.
